Companies by HQ LocationTech Companies and Startups Headquartered in Cambridge
157 companies in this collection.
List of companies headquartered in Cambridge
| Company Name | Description | Year Founded | Total Amount Raised |
|---|---|---|---|
Foundation Alloy leverage advanced materials technology to design novel alloys optimized for additive manufacturing. | 2022 | $10,500,000 | |
Digital twins are revolutionizing industries from aerospace to agriculture. Istari makes them simple and more secure, unlocking models and simulations for better products - better everything. A faster, cheaper, greener digital future awaits.
With Istari, | 2022 | $13,000,000 | |
Founded by Flagship Pioneering, Empress re-imagines the process of small molecule drug discovery. Our bioplatform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to focus on endogenous sources of inherently d | 2022 | $50,000,000 | |
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. | 2022 | $270,000,000 | |
Sleepagotchi rewards users with a digital collectible for sticking to a consistent sleep schedule that they set for themselves in order to promote healthy sleeping habits. | 2022 | $3,500,000 | |
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics. | 2022 | $75,000,000 | |
Montai is harnessing nature's power through digital technology to treat and prevent chronic disease, hence improving health outcomes for as many people as possible. To address this crucial global concern, the business is pioneering cutting-edge technology | 2022 | $50,000,000 | |
Wild Microbes is a next-generation microbial platform that makes everything from plastics to proteins. They develop new microbial strains, making scaling sustainable products faster and cheaper than ever. | 2022 | $3,300,000 | |
Mantel is developing the first molten-salt based carbon capture technology. Our molten borates are designed to operate at the high temperatures found inside boilers, kilns, and furnaces – enabling highly efficient carbon capture that has not been possible | 2022 | $2,000,000 | |
Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States. | 2022 | $7,000,000 | |
StataDX is building the world's first point-of-care diagnostics platform for Neurology. | 2022 | $2,700,000 | |
We develop scalable quantum computers to tackle the world’s hardest computational challenges. Join us: https://jobs.polymer.co/atlantic-quantum. | 2022 | $9,000,000 | |
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is | 2022 | $70,000,000 | |
Pramana, Inc is a new health technology company from nference that enables digital transformation for next-generation pathology at medical centers and pathology labs. Pramana offers a first-in-class Digital Pathology as a Service (DPaaS) solution by provid | 2022 | $30,000,000 | |
NuMind is a manufacturing company currently based in Cambridge, Massachusetts, United States. It has been founded in 2022 by Etienne Bernard and Samuel Bernard. | 2022 | $3,500,000 | |
Deploy machine learning models in minutes using infrastructure managed for you. | 2021 | $3,500,000 | |
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by indust | 2021 | $550,000,000 | |
Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory diseases. | 2021 | $95,000,000 | |
Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, | 2021 | $205,000,000 | |
Chroma Medicine is a new genomic medicine company working on epigenetic editing. Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, to revolutionize the treatment of genet | 2021 | $260,000,000 | |
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases. | 2021 | $134,000,000 | |
Atavistik Bio is a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control | 2021 | $60,000,000 | |
Yard Stick measures soil carbon. Scientists and farmers alike know that climate-friendly agricultural practices have the potential to remove atmospheric CO2 at gigaton/year scale. When these practices are adopted, more carbon is stored in soils, improving | 2021 | $25,420,858 | |
Dianthus is the world’s only AI-first E-commerce company – built from the ground up to help small to medium E-commerce brands. | 2021 | $11,500,000 | |
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA. Their First in Class approach for protein editing advances beyond genome editing to direct modification of the proteome. | 2021 | $40,000,000 | |
K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies. | 2021 | $100,000,000 | |
Stack is a B2B SaaS computer vision information system company that aims to rethink the way warehouses are managed across the United States. | 2021 | ||
Gesund.ai orchestrates the AI as-a-Medical Device lifecycle, providing privacy-centered access to diverse yet standardized medical data sources, and a unique analytical toolbox that fosters clinical validation, regulatory clearance and effective marketing. | 2021 | $2,000,000 | |
Thousands of collectors use evaluate.market to analyze NFTs. We are a remote, venture-backed company that is changing how people buy, sell, and analyze digital collectibles. Connect with us on Twitter and join our Discord to learn more. | 2021 | $7,291,992 | |
Robigo is a biopesticide engineering the plant microbiome to reduce disease in crops. | 2021 | $11,150,000 | |
ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease. RNA delivery systems with a comprehensive RNA platform that allows for an all-RNA system for coding, editing, and gene insertion to produce new medications. | 2021 | $300,000,000 | |
Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential of functional molecular mimics. The MIMiCTM platform, developed by the business, is a computationally driven bio platform for developing novel the | 2021 | $50,000,000 | |
FYTO is a technology company that develops systems that grow high quality crops using much less resources. | 2021 | $32,959,998 | |
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases. | 2020 | $107,000,000 | |
IoT-enabled analytics platform providing data-driven optimization of industrial liquid systems for manufacturing | 2020 | $7,019,999 | |
Verve's mission is to improve the limits of worker safety and well-being by pioneering the integration of robotics into functional apparel. They commercialize a lightweight, one-size fits most wearable that powers and protects workers all day long, so they | 2020 | $25,559,480 | |
Woho enables a new way to build, assembling a team, network, and system to construct from low to high-rise structures with unprecedented quality, precision, and efficiency. The company was founded in 2020 and based in Cambridge, Massachusetts. | 2020 | $4,500,000 | |
Common Sense Machines is building artificial intelligence that learns to translate the world into a 3D simulation. Our platform, Real-to-Sim-to-Real, leverages the flexibility of human-like learning and the speed and precision of machines to enable one-sho | 2020 | $7,579,994 | |
Bicara Therapeutics, a wholly-owned subsidiary of Biocon based in Boston, U.S., is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology. Bicara enables access to the thriving innovation ecosystem in the U.S. | 2020 | $148,000,000 | |
SalioGen Therapeutics advances in curative genetic therapies using its Exact DNA Integration Technology (EDIT) platform, a mammal-derived genome engineering technology. It is focused on providing durable, safe, and affordable non-viral gene therapies to mo | 2020 | $135,000,000 | |
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. | 2020 | $40,000,000 | |
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and | 2020 | $127,000,000 | |
As schools and businesses return to work, they will be met with a number of new challenges: keeping students and employees safe, tracking outbreaks, and communicating to the public that they are taking responsible precautions. CoVerified provides a profe | 2020 | ||
Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity. | 2020 | $182,000,000 | |
Silvertree is on a mission to empower the world’s aging population. We are developing next-gen wearable technology that provides the right form of safety and connection for active older adults. Aging is a personal experience, yet aging with dignity and ind | 2020 | $12,500,000 | |
Novus is a communication technologies company whose products focus on productivity and creativity in content creation using the state-of-the-art approaches in Artificial Intelligence. | 2020 | 4555000 EUR | |
Hosta Labs automates the analysis of images and videos of interior structures for property insurance carriers to provide a full in-depth view of accurate replacement values and risks in the underwriting process and on raw material quantities and mitigation | 2020 | $14,742,466 | |
Akooda helps employees to navigate the digital, hybrid, and remote work world using AI and data science. | 2020 | $11,000,000 | |
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease. Founded by world-renowned experts in renal disease, Walden is applying its unique, systems-based approach to address the intersection between the patholo | 2020 | $51,000,000 | |
THEON Therapeutics is a patient-focused drug discovery company developing small molecule correctors of RNA pathobiology. The company was founded in 2020 and based in Boston, Massachusetts. | 2020 | $13,374,999 | |
Carbon Counts is creating a unique mobile game that will engage people to individually and collectively impact climate change | 2020 | $7,000,000 | |
Founded by Stuart Schreiber, Benjamin Cravatt, Stephanie Dougan, and Vasanthi Viswanathan, Kojin is accelerating a drug discovery platform that connects complex cell states to known biochemical processes such as ferroptosis, or iron-dependent cell death, a | 2020 | $60,000,000 | |
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. We are u | 2020 | $161,000,000 | |
Faze Medicines is a biotechnology company harnessing the groundbreaking new science of biomolecular condensates to create medical breakthroughs. | 2020 | $81,000,000 | |
TalkTo Inc. develops mobile applications. The Company offers an application that enables users to text directly to stores, restaurants, hotels, and other types of businesses. TalkTo serves the consumer discretionary sector. | 2020 | $3,000,000 | |
MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease. | 2020 | $236,000,000 | |
Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients. | 2020 | $4,625,000 | |
Metrika is a monitoring and analytics platform that provides visibility and actionable insights into blockchain networks. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts, United States. | 2019 | $21,700,000 | |
Watershed Informatics catalyzes discovery by democratizing access to bioinformatics tools for biologists. It enables life sciences organizations of any size to perform mission-critical bioinformatics analyses (such as bulk, single-cell, and spatial transcr | 2019 | $16,200,000 | |
Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging | 2019 | $136,200,000 | |
Einblick is a visual data computing platform that provides the fastest way for organizations to understand the past, predict the future, and make the best data-driven decisions for their business. Einblick customers include a large luxury German car brand, | 2019 | $6,000,000 | |
Vedere is developing cutting-edge gene therapy products to restore functional vision to patients who have suffered vision loss from Inherited Retinal Degenerations (IRDs), as well as other causes of both genetic and non-genetic vision loss. While the vast | 2019 | $98,000,000 | |
A cancer diagnosis is something no one wants to hear. Too often, cancer is detected late, once it has spread and treatment options are limited. But cancer can be more effectively treated with an intent to cure if caught in the earlier stages. At Thrive, an | 2019 | $367,000,000 | |
Our mission is to create amazing event experience for enterprises.
We are a purpose-built platform for enterprises to conduct memorable online events - client summits, workshops, product launches, thought leadership summits, regional conferences - you nam | 2019 | $38,000,000 | |
Akkio is a technology company that makes AI easy enough for anyone to use. | 2019 | $18,000,000 | |
Satellite Biosciences is leading the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases. Building | 2019 | $101,470,992 | |
Thymmune Therapeutics is a preclinical biotechnology company based in Cambridge, MA applying proprietary insights in thymic engineering to develop and commercialize immune cell therapy products addressing significant opportunities with unmet clinical need | 2019 | $7,000,000 | |
EQRx is committed to making innovative medicines at dramatically lower prices for the benefit of people and society. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the compan | 2019 | $1,900,000,000 | |
Meter is a next-generation volumetric imaging technology in development. | 2019 | $67,500,000 | |
Salient Predictions uses ML & ocean data to provide long range weather forecast for use in diverse industries. | 2019 | $5,647,187 | |
Accial Capital is an impact-focused, tech-enabled investor in small business and consumer loan portfolios in emerging markets | 2018 | $35,000,000 | |
Vincere Bio's mission is to develop small molecules with disease-modifying potential for Parkinson's disease. | 2018 | $1,750,000 | |
Kaiburr Solutions is an emerging provider of software for the investment management industry.
Our next generation enterprise portfolio management system, Saber, addresses front-office challenges for institutional portfolio managers, research analysts and | 2018 | ||
Volta Labs is a biotechnology company that develops scalable automation for genetic engineering. | 2018 | $20,000,000 | |
ZwitterCo provides revolutionary membrane solutions for the treatment of highly-impaired wastewater. | 2018 | $40,375,000 | |
PiiQ RISK; Spear : Deliver the most advanced SPEAR PHISHING attack simulations with complete automation! Advanced Attack protocols, contextualised by end user with complete automation and intuitive management consoles - no experience required! Truly tailor | 2018 | $4,500,000 | |
Gradient A.I. Corp. provides artificial intelligence based financial services. The Company offers solutions for workers' compensation, underwriting, and other financial services. Gradient A.I. serves customers in the United States. | 2018 | $30,953,682 | |
Quaise develops millimeter-wave drilling systems for deep geothermal heat access. Their technology is the only approach in the world with the potential to build geothermal wells at unprecedented depths and temperatures. | 2018 | $70,000,000 | |
Overjet is a software company that develops a platform designed to reduce costs and improve the quality of dental care. It uses artificial intelligence and analyzes dental data to determine what treatments are necessary for the patient, enabling patients t | 2018 | $77,350,000 | |
Pluto is a SaaS company that uses assistive ai to help businesses deepen and sustain relationships with their customers over SMS. They're known for creating light-touch participatory moments that connect the offline and online experience, measurably increa | 2018 | $100,000 | |
Geminus.ai’s hybrid modeling platform simplifies and automates the creation, management, and update of sophisticated AI models for industrial applications. By automatically combining measurement data with physics based simulations, Geminus produces AI mode | 2018 | $9,900,000 | |
Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide. | 2018 | $4,245,999 | |
Pickle Robot is a low cost, collaborative package handling robot that automates several key tasks along the e-commerce supply chain. Package handling is a physically demanding job with extremely high rates of turnover. The rising costs of shipping, compris | 2018 | $37,450,000 | |
Commonwealth Fusion Systems (CFS) is an American company founded in 2018 aiming to build a compact nuclear fusion power plant based on the ARC tokamak reactor concept. The company is based in Cambridge, Massachusetts, and is a spin-off of the Massachusetts | 2018 | $1,999,000,064 | |
Alltrna is the tRNA platform company to decipher tRNA biology and pioneer tRNA therapeutics to treat thousands of diseases. tRNAs play a central role in the translation of mRNA into proteins. tRNA biology modulates the complex code of DNA and RNA across tr | 2018 | $159,000,000 | |
Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeti | 2018 | $109,000,000 | |
The Routing Company is an organization currently based in Cambridge, Massachusetts, United States. It has been founded in 2018. | 2018 | $20,000,000 | |
Our mission is to cure disease by writing the code of life | 2018 | ||
Malta Inc provides energy storage systems. The Company offers electro-thermal energy storage system that collects and stores energy from any power generation source like wind, solar, and fossil fuels. Malta serves customers in the State of Massachusetts. | 2018 | $86,900,000 | |
ConcertAI is a developer of medical research tool suite intended to design and deliver care-based oncology research and data analytics. It is an integrated real-world data and AI-driven solutions to transform how insights are generated and accelerate thera | 2018 | $300,000,000 | |
1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development. The company establishes an understanding of the molecular basis of disease to the granularity at which the world understands sickle | 2018 | $26,650,000 | |
iSee, Inc. operates as a software company. The Company designs and develops an artificial intelligence for self driving cars. iSee serves clients in the United States. | 2017 | $57,736,984 | |
Solo.io, Inc. operates as a venture capital firm. The Company invests in the product development of its enterprise and open-source tools. | 2017 | $171,500,000 | |
Our founder Johnny Monsarrat previously co-created the $54B MMO game market, by founding Turbine (Lord of the Rings Online, Asheron's Call), one of the ''big three'' first MMO game companies, a new category. Warner Bros. bought Turbine for $160M. Now, AR m | 2017 | $2,360,000 | |
Iterative Scopes delivers tools for physicians and life sciences in colorectal cancer and inflammatory bowel disease space. | 2017 | $193,620,000 | |
SenpAI.gg (YC S21) is a gaming coach for the 1.4 billion PC gamers globally. SenpAI.gg’s desktop application makes personalized recommendations in the game and provides post-game feedback to help gamers improve faster. It is the most comprehensive assistan | 2017 | ||
Hydrow, Inc. provides connected indoor rowing machine. The Company offers a connected indoor rowing machine which daily creates live content broadcast straight from the cradle of rowing. Hydrow serves customers worldwide. | 2017 | $367,179,392 | |
Aventior is a global technology company that uses Digital Platforms to assist industrial clients in their digital transformation journey. | 2017 | ||
Biobot Analytics develops cutting-edge technology to transform sewers into public health observatories. Wastewater contains valuable information about the health of communities. We collect it. We analyze it. We tell you how to leverage it to make your city | 2017 | $27,998,736 | |
Laronde is pioneering a platform that offers a completely novel way of modulating human biology. Endless RNA™ (eRNA), is a uniquely engineered RNA that can be programmed to express diverse proteins inside the body. It is persistent, non-immunogenic, allows | 2017 | $490,000,000 |
Page 1 of 2